Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_002462.5(MX1):c.660T>G(p.Asn220Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
MX1 (HGNC:7532): (MX dynamin like GTPase 1) This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that participates in the cellular antiviral response. The encoded protein is induced by type I and type II interferons and antagonizes the replication process of several different RNA and DNA viruses. There is a related gene located adjacent to this gene on chromosome 21, and there are multiple pseudogenes located in a cluster on chromosome 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.660T>G (p.N220K) alteration is located in exon 11 (coding exon 5) of the MX1 gene. This alteration results from a T to G substitution at nucleotide position 660, causing the asparagine (N) at amino acid position 220 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of ubiquitination at N220 (P = 0.0146);Gain of ubiquitination at N220 (P = 0.0146);Gain of ubiquitination at N220 (P = 0.0146);.;Gain of ubiquitination at N220 (P = 0.0146);